Therefore our results could be the reason to design studies that explore the combination of CD8+ T-cells density with high expression of SDF-1 in other types of cancer (for example lung, pancreatic and esophagus-gastric cancer), where current data already showed reduced overall survival in the single marker analysis of SDF-1. This evidence concerns the gene CXCL12 and cancer.